1887
No metrics data to plot.
The attempt to load metrics for this article has failed.
The attempt to plot a graph for these metrics has failed.

Measles in the United States since the Millennium: Perils and Progress in the Postelimination Era

MyBook is a cheap paperback edition of the original book and will be sold at uniform, low price.
  • XML
    75.11 Kb
  • PDF
    4.48 MB
  • HTML
    78.78 Kb
  • Authors: Anne Schuchat1, Amy Parker Fiebelkorn2, William Bellini3
  • Editors: W. Michael Scheld4, James M. Hughes5, Richard J. Whitley6
  • VIEW AFFILIATIONS HIDE AFFILIATIONS
    Affiliations: 1: The National Center for Immunization and Respiratory Diseases, Centers for Disease Control and Prevention, Atlanta, GA 30329; 2: Division of Viral Diseases, The National Center for Immunization and Respiratory Diseases, Centers for Disease Control and Prevention, Atlanta, GA 30329; 3: Division of Viral Diseases, The National Center for Immunization and Respiratory Diseases, Centers for Disease Control and Prevention, Atlanta, GA 30329; 4: Department of Infectious Diseases, University of Virginia Health System, Charlottesville, VA; 5: Division of Infectious Diseases, Department of Medicine, Emory University School of Medicine, Atlanta, GA; 6: Department of Pediatrics, University of Alabama at Birmingham, Birmingham, AL
    • Source: microbiolspec April 2016 vol. 4 no. 2 doi:10.1128/microbiolspec.EI10-0006-2015
  • Received 22 October 2015 Accepted 12 November 2015 Published 08 April 2016
  • Anne Schuchat, [email protected]
image of Measles in the United States since the Millennium: Perils and Progress in the Postelimination Era
    Preview this microbiology spectrum article:
    Preview Magnify
    Zoom in
    Zoomout

    Measles in the United States since the Millennium: Perils and Progress in the Postelimination Era, Page 1 of 2

    | /docserver/preview/fulltext/microbiolspec/4/2/EI10-0006-2015-1.gif /docserver/preview/fulltext/microbiolspec/4/2/EI10-0006-2015-2.gif

  • Abstract:

    This article describes measles and measles vaccination, along with the challenges, successes, and progress in the postelimination era.

  • Citation: Schuchat A, Fiebelkorn A, Bellini W. 2016. Measles in the United States since the Millennium: Perils and Progress in the Postelimination Era. Microbiol Spectrum 4(2):EI10-0006-2015. doi:10.1128/microbiolspec.EI10-0006-2015.

References

1. Goodson J, Seward J. 2015. Measles: 50 years after use of measles vaccine. Infect Dis Clin North Am 29:725–743. [PubMed][CrossRef]
2. Katz S, Hinman A. 2004. Summary and conclusions: Measles Elimination Meeting, 16–17 March 2000. J Infect Dis 189:S43–S47. [PubMed][CrossRef]
3. CDC. 2015. Measles outbreak—California, December 2014–February 2015. MMWR Morb Mortal Wkly Rep 64:153–154. [PubMed]
4. CDC. 2015. Measles—United States, January 4–April 2, 2015. MMWR Morb Mortal Wkly Rep 64:373–376. [PubMed]
5. CS Mott Children’s Hospital. 2015. Safer, with more benefits: parents’ vaccines views shifting. CS Mott Children’s Hospital National Poll on Children’s Health, 6 July 2015 ed, vol 24. University of Michigan Health System, Ann Arbor, MI.
6. Funk C, Rainie L. 1 July 2015, posting date. Americans, politics and science issues. Pew Research Center, Washington, DC. http://www.pewinternet.org/2015/07/01/Americans-Politics-and-Science-Issues/.
7. Newport, F. 6 March 2015, posting date. In U.S., percentage saying vaccines are vital dips slightly. Gallup.com. http://www.gallup.com/poll/181844/percentage-saying-vaccines-vital-dips-slightly.aspx.
8. Orenstein, W. 2006. The role of measles elimination in development of a national immunization program. Pediatr Infect Dis J 25:1093–1101. [PubMed][CrossRef]
9. CDC. 2011. Vaccine-preventable diseases, immunizations, and MMWR—1961–2011. MMWR Morb Mortal Wkly Rep 60(Suppl) :49–57.
10. Orenstein WA, Hinman AR. 1999. The immunization system in the United States—the role of school immunization laws. Vaccine 17(Suppl 3) :S19–S24. [CrossRef]
11. CDC. 1978. Measles and school immunization requirements—United States, 1978. MMWR Morb Mortal Wkly Rep 27:303–304.
12. Atkinson WL, Orenstein W, Krugman S. 1992. The resurgence of measles in the United States, 1989–1990. Annu Rev Med 43:451–463. [PubMed][CrossRef]
13. Hutchins SS, Escolan J, Markowitz LE, Hawkins C, Kimbler A, Morgan RA, Preblud SR, Orenstein WA. 1989. Measles outbreak among unvaccinated preschool-aged children: opportunities missed by health care providers to administer measles vaccine. Pediatrics 83:369–374. [PubMed]
14. NVAC. 1991. The measles epidemic: the problems, barriers, and recommendations. JAMA 266:1547–1552. [PubMed][CrossRef]
15. CDC. 1989. Measles prevention: recommendations of the Immunization Practices Advisory Committee (ACIP). MMWR Morb Mortal Wkly Rep 38:1–18. [PubMed]
16. Santoli JM, Rodewald LE, Maes EF, Battaglia MP, Coronado VG. 1999. Vaccines for Children Program, United States, 1997. Pediatrics 104:e15. [PubMed][CrossRef]
17. CDC. 2014. Benefits from immunization during the Vaccines for Children Program Era-United States, 1994–2013. MMWR Morb Mortal Wkly Rep 63:352–355. [PubMed]
18. CDC. 2015. National, regional, state and selected local area vaccination coverage among adolescents, aged 13–17 years—United States, 2014. MMWR Morb Mortal Wkly Rep 64:784–792. [CrossRef]
19. Papania MJ, Wallace GS, Rota PA, Icenogle JP, Fiebelkorn AP, Armstrong GL, Reef SE, Redd SB, Abernathy ES, Barskey AE, Hao L, McLean Huong Q, Rota J, Bellini WJ, Seward JF. 2014. Elimination of endemic measles, rubella, and congenital rubella syndrome from the Western Hemisphere: the U.S. experience. JAMA Pediatr 168:148–155. [PubMed][CrossRef]
20. Parker Fiebelkorn A, Redd SB, Gallagher K, Rota PA, Rota J, Bellini W, Seward J. 2010. Measles in the United States during the postelimination era. J Infect Dis 202:1520–1528. [PubMed][CrossRef]
21. CDC. 2015. Map of imported cases, by state, 2001 to 2015. CDC, Atlanta, GA.
22. Parker AA, Staggs W, Dayan GH, Ortega-Sánchez IR, Rota PA, Lowe L, Boardman P, Teclaw R, Graves C, LeBaron CW. 2006. Implications of a 2005 measles outbreak in Indiana for sustained elimination of measles in the United States. N Engl J Med 355:447–455. [PubMed][CrossRef]
23. CDC. 2004. Epidemiology of measles—United States, 2001–2003. MMWR Morb Mortal Wkly Rep 53:713–716. [PubMed]
24. CDC. 2004. Multistate investigation of measles among adoptees from China—April 2004. MMWR Morb Mortal Wkly Rep 53:1–2. [PubMed]
25. CDC. 2007. Measles among adults associated with adoption of children in China—California, Missouri, and Washington, July–August 2006. MMWR Morb Mortal Wkly Rep 56:144–146. [PubMed]
26. Sugerman DE, Barsky AE, Delea MG, Ortega-Sanchez IR, Bi D, Ralston JK, Rota PA, Waters-Montijo K, LeBaron C. 2010. Measles outbreak in a highly vaccinated population, San Diego, 2008: role of the intentionally undervaccinated. Pediatrics 125:747–755. [PubMed][CrossRef]
27. Gust DA, Darling N, Kennedy A, Schwartz B. 2008. Parents with doubts about vaccines: which vaccines and reasons why. Pediatrics 122:718–725. [PubMed][CrossRef]
28. Institute of Medicine. 2011. Adverse Effects of Vaccines: Evidence and Causality. The National Academies Press, Washington, DC.
29. Institute of Medicine. 2004. Immunization safety review: vaccines and autism, p 214. In The National Academies Press (ed), Vaccines and Autism. The National Academies Press, Washington, DC.
30. Godlee F, Smith J, Marcovitch H. 2011. Wakefield’s article linking MMR vaccine and autism was fraudulent. BMJ 342:64–66. [PubMed][CrossRef]
31. American Academy of Pediatrics. 1999. Joint statement of the American Academy of Pediatrics (AAP) and the United States Public Health Service (USPHS). Pediatrics 104:568–569. [PubMed][CrossRef]
32. Taylor LE, Swerdfeger AL, Eslick G. 2014. Vaccines are not associated with autism: an evidence-based meta-analysis of case-control and cohort studies. Vaccine 32:3623–3629. [PubMed][CrossRef]
33. Thompson WW, Price C, Goodson B, Shay DK, Benson P, Hinrichsen VL, Lewis E, Eriksen E, Ray P, Marcy SM, Dunn J, Jackson LA, Lieu TA, Black S, Stewart G, Weintraub ES, Davis RL, DeStefano F. 2007. Early thimerosal exposure and neuropsychological outcomes at 7 to 10 years. N Engl J Med 357:1281–1292. [PubMed][CrossRef]
34. Price CS, Thompson WW, Goodson B, Weintraub ES, Croen LA, Hinrichsen VL, Marcy M, Robertson A, Eriksen E, Lewis E, Bernal P, Shay D, Davis RL, DeStefano F. 2010. Prenatal and infant exposure to thimerosal from vaccines and immunoglobulins and risk of autism. Pediatrics 126:656–664. [PubMed][CrossRef]
35. National Vaccine Injury Compensation Program. 12 November 2013, posting date. Vaccine injury table. Health Resources and Services Administration, Rockville, MD. http://www.hrsa.gov/vaccinecompensation/vaccinetable.html.
36. Kennedy A, LaVail K, Nowak G, Basket M, Landry S. 2011. Confidence about vaccines in the United States: understanding parents’ perceptions. Health Affairs 30:1151–1159. [PubMed][CrossRef]
37. Department of Health. 1998, posting date. NHS immunisation statistics, England: 1997-98. Department of Health, London, United Kingdom. http://webarchive.nationalarchives.gov.uk/20130107105354/ http://www.dh.gov.uk/prod_consum_dh/groups/dh_digitalassets/@dh/@en/documents/digitalasset/dh_4021496.pdf.
38. Department of Health. 2004, posting date. NHS immunisation statistics, England: 2003-04. Department of Health, London, United Kingdom. http://webarchive.nationalarchives.gov.uk/20130107105354/ http://www.dh.gov.uk/prod_consum_dh/groups/dh_digitalassets/@dh/@en/documents/digitalasset/dh_4099577.pdf.
39. Editorial Team. 2008. Measles once again endemic in the United Kingdom. Euro Surveill 13(27) :pii=18919.
40. Kennedy A, Basket M, Sheedy K. 2011. Vaccine attitudes, concerns, and information sources reported by parents of young children: results from the 2009 HealthStyles survey. Pediatrics 127:S92–S99. [PubMed][CrossRef]
41. CDC. 2015. National, state, and selected local area vaccination coverage among children aged 19–35 months—United States, 2014. MMWR Morb Mortal Wkly Rep 64:889–896. [CrossRef]
42. Wang E, Clymer J, Davis-Hayes C, Buttenheim A. 2014. Nonmedical exemptions from school immunization requirements: a systematic review. Am J Public Health 104:e62–e84. [PubMed][CrossRef]
43. Lieu TA, Ray TG, Klein NP, Chung C, Kulldorff M. 2015. Geographic clusters in underimmunization and vaccine refusal. Pediatrics 135:280–289. [PubMed][CrossRef]
44. CDC. 2015. Vaccination coverage among children in kindergarten—United States, 2014-15 school year. MMWR Morb Mortal Wkly Rep 64:897–904. [CrossRef]
45. CDC. 2013. Notes from the field: measles outbreak associated with a traveler returning from India—North Carolina, April–May 2013. MMWR Morb Mortal Wkly Rep 62:753. [PubMed]
46. CDC. 2013. Notes from the field: measles outbreak among members of a religious community—Brooklyn, New York, March–June 2013. MMWR Morb Mortal Wkly Rep 62:752–753. [PubMed]
47. CDC. 2013. Notes from the field: measles—United States, January 1–August 24, 2013. MMWR Morb Mortal Wkly Rep 62:741–743. [PubMed]
48. Omer SB, Enger KS, Moulton LH, Halsey NA, Stokley S, Salmon DA. 2008. Geographic clustering of nonmedical exemptions to school immunization requirements and associations with geographic clustering of pertussis. Am J Epidemiol 168:1389–1396. [PubMed][CrossRef]
49. Bradford WD, Mandich A. 2015. Some state vaccination laws contribute to greater exemption rates and disease outbreaks in the United States. Health Affairs 34:1383–1390. [PubMed][CrossRef]
50. Omer SB, Richards JL, Ward M, Bednarczyk R. 2012. Vaccination policies and rates of exemption from immunization, 2005–2011. N Engl J Med 367:1170–1171. [PubMed][CrossRef]
51. CDC. 2014. Measles—United States, January 1–May 23, 2014. MMWR Morb Mortal Wkly Rep 63:496–499. [PubMed]
52. CDC. 2015. Progress toward measles elimination—Philippines, 1998–2014. MMWR Morb Mortal Wkly Rep 64:357–362. [PubMed]
53. NVAC. 2013. Protecting the public’s health: critical functions of the Section 317 Immunization Program—a report of the National Vaccine Advisory Committee. Public Health Rep 128:78–95. [PubMed]
54. Fiebelkorn AP, Redd SB, Kuhar DT. 2015. Measles in healthcare facilities in the United States during the postelimination era, 2001–2014. Clin Infect Dis 61:615–618. [PubMed][CrossRef]
55. Fiebelkorn AP, Seward JF, Orenstein WA. 2014. A global perspective of vaccination of healthcare personnel against measles: systematic review. Vaccine 32:4823–4839. [PubMed][CrossRef]
56. Ortega-Sanchez IR, Vijayaraghavan M, Barskey AE, Wallace G. 2014. The economic burden of sixteen measles outbreaks on United States public health departments in 2011. Vaccine 32:1311–1317. [PubMed][CrossRef]
57. Omer SB, Peterson D, Curran EA, Hinman A, Orenstein W. 2014. Legislative challenges to school immunization mandates, 2009–2012. JAMA 311:620–621. [PubMed][CrossRef]
58. Yang Y, Silverman R. 2015. Legislative prescriptions for controlling nonmedical vaccine exemptions. JAMA 313:247–248. [PubMed][CrossRef]
59. Feikin DR, Lezotte DC, Hamman RF, Salmon DA, Chen RT, Hoffman RE. 2000. Individual and community risks of measles and pertussis associated with personal exemptions to immunization. JAMA 284:3145–3150. [PubMed][CrossRef]
60. Omer SB, Pan WY, Halsey NA, Stokley S, Moulton LH, Navar AM, Pierce M, Salmon DA. 2006. Nonmedical exemptions to school immunization requirements: secular trends and association of state policies with pertussis incidence. JAMA 296:1757–1763. [PubMed][CrossRef]
61. Mello MM, Studdert DM, Parmet WE. 2015. Shifting vaccination politics—the end of personal-belief exemptions in California. N Engl J Med 373:785–787. [PubMed][CrossRef]
62. McCoy C. 2015. Why are vaccination rates dropping in America? New Republic http://www.newrepublic.com/article/122367/why-are-vaccination-rates-dropping-america.
63. Gostin LO. 2015. Law, ethics, and public health in the vaccination debates: politics of the measles outbreak. JAMA 313:1099–1100. [PubMed][CrossRef]
64. CDC. 2014. Progress toward regional measles elimination—worldwide, 2000–2013. MMWR Morb Mortal Wkly Rep 63:1034–1038. [PubMed]
65. Fiebelkorn AP, Redd SB, Gastañaduy PA, Clemmons N, Rota PA, Rota JS, Bellini WJ, Wallace GS. 13 December 2015. A comparison of post-elimination measles epidemiology in the United States, 2009–2014 versus 2001–2008. J Pediatr Infect Dis Soc pii:piv080. [Epub ahead of print] PMID:2666559. [PubMed]
Loading

Article metrics loading...

/content/journal/microbiolspec/10.1128/microbiolspec.EI10-0006-2015
2016-04-08
2019-10-18

Abstract:

This article describes measles and measles vaccination, along with the challenges, successes, and progress in the postelimination era.

Highlighted Text: Show | Hide
Loading full text...

Full text loading...

/deliver/fulltext/microbiolspec/4/2/EI10-0006-2015.html?itemId=/content/journal/microbiolspec/10.1128/microbiolspec.EI10-0006-2015&mimeType=html&fmt=ahah

Figures

Measles in the United States since the Millennium: Perils and Progress in the Postelimination Era
[com.pub2web.rdf.cci.facet.ContentItem[id=http://asm.metastore.ingenta.com/content/author/microbiolspec/10.1128/microbiolspec.EI10-0006-2015-1,webId=/content/author/microbiolspec/10.1128/microbiolspec.EI10-0006-2015-1,properties={foaf_givenname=Anne, foaf_name=Anne Schuchat, foaf_surname=Schuchat, pub_isAffiliatedWith=[com.pub2web.rdf.cci.facet.ContentItem[id=http://asm.metastore.ingenta.com/content/affiliation/microbiolspec/10.1128/microbiolspec.EI10-0006-2015-aff1]]}], com.pub2web.rdf.cci.facet.ContentItem[id=http://asm.metastore.ingenta.com/content/author/microbiolspec/10.1128/microbiolspec.EI10-0006-2015-2,webId=/content/author/microbiolspec/10.1128/microbiolspec.EI10-0006-2015-2,properties={foaf_givenname=Amy Parker, foaf_name=Amy Parker Fiebelkorn, foaf_surname=Fiebelkorn, pub_isAffiliatedWith=[com.pub2web.rdf.cci.facet.ContentItem[id=http://asm.metastore.ingenta.com/content/affiliation/microbiolspec/10.1128/microbiolspec.EI10-0006-2015-aff2]]}], com.pub2web.rdf.cci.facet.ContentItem[id=http://asm.metastore.ingenta.com/content/author/microbiolspec/10.1128/microbiolspec.EI10-0006-2015-3,webId=/content/author/microbiolspec/10.1128/microbiolspec.EI10-0006-2015-3,properties={foaf_givenname=William, foaf_name=William Bellini, foaf_surname=Bellini, pub_isAffiliatedWith=[com.pub2web.rdf.cci.facet.ContentItem[id=http://asm.metastore.ingenta.com/content/affiliation/microbiolspec/10.1128/microbiolspec.EI10-0006-2015-aff3]]}]]
Citation: Schuchat A, Fiebelkorn A, Bellini W. 2016. Measles in the united states since the millennium: perils and progress in the postelimination era. microbiolspec 4(2): doi:10.1128/microbiolspec.EI10-0006-2015
/content/microbiolspec/10.1128/microbiolspec.EI10-0006-2015.fig1
FIGURE 1

Measles, United States, 1962 to 2014. (Adapted from reference 1 with permission.)

microbiolspec/4/2/EI10-0006-2015-fig1_thmb.gif
microbiolspec/4/2/EI10-0006-2015-fig1.gif
Image of FIGURE 1

Click to view

FIGURE 1

Measles, United States, 1962 to 2014. (Adapted from reference 1 with permission.)

Source: microbiolspec April 2016 vol. 4 no. 2 doi:10.1128/microbiolspec.EI10-0006-2015
Permissions and Reprints Request Permissions
Download as Powerpoint
/content/microbiolspec/10.1128/microbiolspec.EI10-0006-2015.fig2
FIGURE 2

Measles virus-containing vaccine coverage among 19- to 35-month-olds (Immunization Information Survey, 1967 to 1985, and National Immunization Survey, 1994 to 2014 [ 17 ]) and among 13- to 17-year-olds (NIS-teen), ( 18 ) by year. (Adapted from references 17 , 18 with permission.)

microbiolspec/4/2/EI10-0006-2015-fig2_thmb.gif
microbiolspec/4/2/EI10-0006-2015-fig2.gif
Image of FIGURE 2

Click to view

FIGURE 2

Measles virus-containing vaccine coverage among 19- to 35-month-olds (Immunization Information Survey, 1967 to 1985, and National Immunization Survey, 1994 to 2014 [ 17 ]) and among 13- to 17-year-olds (NIS-teen), ( 18 ) by year. (Adapted from references 17 , 18 with permission.)

Source: microbiolspec April 2016 vol. 4 no. 2 doi:10.1128/microbiolspec.EI10-0006-2015
Permissions and Reprints Request Permissions
Download as Powerpoint
/content/microbiolspec/10.1128/microbiolspec.EI10-0006-2015.fig3
FIGURE 3

Reported cases of measles by region of importation, 2001 to 2015. (Adapted from reference 20 with permission.)

microbiolspec/4/2/EI10-0006-2015-fig3_thmb.gif
microbiolspec/4/2/EI10-0006-2015-fig3.gif
Image of FIGURE 3

Click to view

FIGURE 3

Reported cases of measles by region of importation, 2001 to 2015. (Adapted from reference 20 with permission.)

Source: microbiolspec April 2016 vol. 4 no. 2 doi:10.1128/microbiolspec.EI10-0006-2015
Permissions and Reprints Request Permissions
Download as Powerpoint
/content/microbiolspec/10.1128/microbiolspec.EI10-0006-2015.fig4
FIGURE 4

Map of imported measles cases, by state, 2001 to 2015. (Source, Division of Viral Diseases, CDC [ 51 ].)

microbiolspec/4/2/EI10-0006-2015-fig4_thmb.gif
microbiolspec/4/2/EI10-0006-2015-fig4.gif
Image of FIGURE 4

Click to view

FIGURE 4

Map of imported measles cases, by state, 2001 to 2015. (Source, Division of Viral Diseases, CDC [ 51 ].)

Source: microbiolspec April 2016 vol. 4 no. 2 doi:10.1128/microbiolspec.EI10-0006-2015
Permissions and Reprints Request Permissions
Download as Powerpoint

Tables

Measles in the United States since the Millennium: Perils and Progress in the Postelimination Era
[com.pub2web.rdf.cci.facet.ContentItem[id=http://asm.metastore.ingenta.com/content/author/microbiolspec/10.1128/microbiolspec.EI10-0006-2015-1,webId=/content/author/microbiolspec/10.1128/microbiolspec.EI10-0006-2015-1,properties={foaf_givenname=Anne, foaf_name=Anne Schuchat, foaf_surname=Schuchat, pub_isAffiliatedWith=[com.pub2web.rdf.cci.facet.ContentItem[id=http://asm.metastore.ingenta.com/content/affiliation/microbiolspec/10.1128/microbiolspec.EI10-0006-2015-aff1]]}], com.pub2web.rdf.cci.facet.ContentItem[id=http://asm.metastore.ingenta.com/content/author/microbiolspec/10.1128/microbiolspec.EI10-0006-2015-2,webId=/content/author/microbiolspec/10.1128/microbiolspec.EI10-0006-2015-2,properties={foaf_givenname=Amy Parker, foaf_name=Amy Parker Fiebelkorn, foaf_surname=Fiebelkorn, pub_isAffiliatedWith=[com.pub2web.rdf.cci.facet.ContentItem[id=http://asm.metastore.ingenta.com/content/affiliation/microbiolspec/10.1128/microbiolspec.EI10-0006-2015-aff2]]}], com.pub2web.rdf.cci.facet.ContentItem[id=http://asm.metastore.ingenta.com/content/author/microbiolspec/10.1128/microbiolspec.EI10-0006-2015-3,webId=/content/author/microbiolspec/10.1128/microbiolspec.EI10-0006-2015-3,properties={foaf_givenname=William, foaf_name=William Bellini, foaf_surname=Bellini, pub_isAffiliatedWith=[com.pub2web.rdf.cci.facet.ContentItem[id=http://asm.metastore.ingenta.com/content/affiliation/microbiolspec/10.1128/microbiolspec.EI10-0006-2015-aff3]]}]]
Citation: Schuchat A, Fiebelkorn A, Bellini W. 2016. Measles in the united states since the millennium: perils and progress in the postelimination era. microbiolspec 4(2): doi:10.1128/microbiolspec.EI10-0006-2015
/content/microbiolspec/10.1128/microbiolspec.EI10-0006-2015.T1
TABLE 1

Characteristics of recent outbreaks of measles in the United States with >20 cases

Generic image for table

Click to view

TABLE 1

Characteristics of recent outbreaks of measles in the United States with >20 cases

Source: microbiolspec April 2016 vol. 4 no. 2 doi:10.1128/microbiolspec.EI10-0006-2015
/content/microbiolspec/10.1128/microbiolspec.EI10-0006-2015.T2
TABLE 2

Comparison of key variables from measles cases reported during 2001 to 2008 versus 2009 to 2014

Generic image for table

Click to view

TABLE 2

Comparison of key variables from measles cases reported during 2001 to 2008 versus 2009 to 2014

Source: microbiolspec April 2016 vol. 4 no. 2 doi:10.1128/microbiolspec.EI10-0006-2015

Supplemental Material

No supplementary material available for this content.

Back to top
This is a required field
Please enter a valid email address
Please check the format of the address you have entered.
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error